Atlas FDA

MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY

FDA premarket approval P040044/S050 · decided 2014-01-24

Approval details

PMA number
P040044
Supplement
S050
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2013-12-26
Decision date
2014-01-24
Days to decision
29 days
Decision code
OK30
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
CHANGES TO THE HYDROGEL DRYING PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.